Fiche centre
Institut Gustave Roussy
Villejuif — France
Essais liés3clinical trials
VilleVillejuiflocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03436485
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ODM-208 | Cancer | Phase 1/2 | NCT03436485 | CYPIDES — Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer | ACTIVE_NOT_RECRUITING |
| Sacituzumab govitecan-hziy | Cancer | Phase 3 | NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) | ACTIVE_NOT_RECRUITING |
| BIBX 1382 | Cancer | Phase 1 | NCT00003980 | BIBX 1382 in Treating Patients With Solid Tumors | SUSPENDED |